Anti-Human 4-1BBR (CD137)

Pricing & Details

Product No.B391
Protein
4-1BBR
Formats AvailableView All
Product Type
Polyclonal Antibody
Alternate Names
4-1BB Receptor, TNFRSF9, CD137 Antigen, T-Cell Antigen ILA
Applications
ELISA Cap
,
FC
,
ICC
,
WB
Prod No.
Size
Price
Avail.
Qty
Add to cart
B391-25 µg
25 µg
$195.00
In stock
Max:
Min: 1
Step: 1
B391-100 µg
100 µg
$389.00
In stock
Max:
Min: 1
Step: 1

Antibody Details

Product Details

Reactivity Species
Human
Host Species
Goat
Immunogen
Purified Recombinant Human 4-1BB Receptor (>98%) (Accession # Q07011)
Formulation
This antigen affinity purified polyclonal antibody has been 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 containing 5.0% w/v trehalose with no calcium, magnesium, or preservatives present.
Storage and Handling
The lyophilized antigen affinity purified polyclonal antibody can be stored desiccated at -20°C to -70°C for twelve months from date of receipt. The reconstituted antibody can be stored for at least four weeks at 2-8°C. For long-term storage of the reconstituted antibody, aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. No detectable loss of activity was observed after six months.
Country of Origin
USA
Applications and Recommended Usage?
Quality Tested by Leinco
FC It is recommended to use the indirect method for signal enhancement when enumerating cells expressing 4-1BB Receptor. A suggested method would be to stain cells expressing 4-1BB Receptor with 0.25 µg per 1 - 2.5 x 105 cells in a total staining volume of ≤200 µl followed by PN:G641.
WB To detect Human 4-1BB Receptor this polyclonal antibody can be used at a concentration of 0.1 - 0.2 µg/ml. This polyclonal antibody should be used in conjunction with compatible second-step reagents such as PN:G505 and a chromogenic substrate such as PN:T343. The detection limit for Human 4-1BB Receptor is 0.5 ng/lane under either reducing or non-reducing conditions. The sensitivity of detection may increase up to 50 fold when a chemiluminescent substrate is used. A suitable Western blotting control is PN:F156.
ELISA Sandwich This antibody is useful as the capture antibody in a sandwich ELISA. The suggested coating concentration is 0.4 ng/ml. A suitable detection antibody is PN:B392 at a concentration of approximately 0.1 - 0.4 µg/ml. When used in conjunction with an optimal second step reagent such as PN:A106 and a chromogenic substrate such as PN:T118, the sensitivity of this sandwich ELISA is ~4 ng/well. A suggested standard for this assay is PN:F156.
Other Applications Reported In Literature ?
ICC In Immunocytochemistry, this antibody will detect 4-1BB in cells. The working dilution is 2 - 15 μg/mL.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Goat Anti-Human 4-1BB Receptor recognizes Human 4-1BB Receptor. This antigen affinity purified polyclonal antibody was purified using a proprietary chromatographic technique that includes covalently immobilizing the antigen proteins or peptides to agarose based beads. This purification method enhances specificity, reduces nonspecific binding of extraneous IgG and provides you with the most reliable reagent available for your early discovery research.
Background
Human 4-1BB Receptor, a member of the TNF superfamily of receptors, is mainly expressed on the surface of a variety of T cells, but also found in B cells, monocytes, and various transformed cell lines. 4-1BB Receptor binds to 4-1BBL to provide a co-stimulatory signal for T lymphocytes. Signaling by 4-1BB Receptor has been implicated in the antigen-presentation process and generation of cytotoxic T cells.

Antigen Details

Protein
PubMed
NCBI Gene Bank ID
Elisa Sandwich Protocol
Flow Cytometry
General Western Blot Protocol
Prod No.
Description
B391
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Cookie Policy
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy.